Skip to content
Open access · CC-BY via OpenAlex

Effects of taurine supplementation on metabolic health and biological aging in healthcare workers: A protocol for a triple-blinded, Bayesian-optimized phase II randomized controlled trial

Mandy HM Chu, Jacky K. M. Lai, Anna Lee, William K. K. Wu, Ziheng Huang, Man Kin Henry Wong, Laptin Ho, Hao Su, Samantha S. M. Ho, Xinbo Xu, Warren Pavey, David J. R. Morgan, Matthew T.V. Chan, Kwok Ming Ho

PLoS ONE · 2026

Abstract

BACKGROUND: Metabolic-related diseases become increasingly prevalent with age. Recent experimental evidence suggests that taurine (2-aminoethanesulfonic acid) deficiency contributes to these conditions, despite taurine being classified as a conditionally essential amino acid. PURPOSE: This study aims to assess whether a 6-month oral taurine supplementation program improves blood glucose control and other health parameters among healthcare workers. METHODS: This study is a Bayesian-optimized phase II 1:1 randomized controlled trial. Participants will be randomly assigned to receive oral taurine (3 g/day) or an indistinguishable placebo for 6 months, stratified by (a) diabetes mellitus status and (b) age > 45 years. Assuming non-informative priors, posterior probabilities of effectiveness in reducing glycated hemoglobin (HbA1c) will be evaluated after enrollment of 20, 40, and 60 participants, if outcome data are available at those timepoints, to determine whether the trial should be stopped early for futility or superiority, prior to the planned total enrollment of 80 participants (protocol 1.4 on 19th September 2025). OUTCOMES: The primary outcome is the proportion of participants achieving any reduction in HbA1c at 6 months compared with baseline. Secondary outcomes include changes in plasma lipid levels, blood pressure, PhenoAge, body weight, and skin autofluorescence index. DISCUSSION: This phase II trial applies a Bayesian-optimized design to evaluate the potential health benefits of oral taurine supplementation. The findings will inform whether a sufficiently powered phase III randomized controlled trial is warranted to define the role of taurine in promoting metabolic health. TRIAL REGISTRATION: This trial is registered with the Chinese Clinical Trial registry (https://www.chictr.org.cn/hvshowprojectEN.html?id=277124&v=1.02025-05-21; Identifier: ChiCTR2500102879).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1371/journal.pone.0350389
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Chu, M.H., Lai, J.K.M., Lee, A., Wu, W.K.K., Huang, Z., Wong, M.K.H., Ho, L., Su, H., Ho, S.S.M., Xu, X., Pavey, W., Morgan, D.J.R., Chan, M.T., &amp; Ho, K.M. (2026). Effects of taurine supplementation on metabolic health and biological aging in healthcare workers: A protocol for a triple-blinded, Bayesian-optimized phase II randomized controlled trial. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0350389
Vancouver
Chu MH, Lai JKM, Lee A, Wu WKK, Huang Z, Wong MKH, et al. Effects of taurine supplementation on metabolic health and biological aging in healthcare workers: A protocol for a triple-blinded, Bayesian-optimized phase II randomized controlled trial. PLoS ONE. 2026. doi:10.1371/journal.pone.0350389.
BibTeX
@article{mandy2026Effect, title = {Effects of taurine supplementation on metabolic health and biological aging in healthcare workers: A protocol for a triple-blinded, Bayesian-optimized phase II randomized controlled trial}, author = {Mandy HM Chu and Jacky K. M. Lai and Anna Lee and William K. K. Wu and Ziheng Huang and Man Kin Henry Wong and Laptin Ho and Hao Su and Samantha S. M. Ho and Xinbo Xu and Warren Pavey and David J. R. Morgan and Matthew T.V. Chan and Kwok Ming Ho}, journal = {PLoS ONE}, year = {2026}, doi = {10.1371/journal.pone.0350389}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings